The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
@sustain https://www.investormeetcompany.com/
There is no shame in seeking help pennystockgrowth. Quite the opposite. Consider it. Both for yourself AND those around you. Sometimes our behaviour is a distraction from what we should really be dealing with.
Seems to me 'the market' has been cautious but not pessimistic (unlike previous times) after recent news, hence no sell off today prior to presentation. Any positivity especially on further sales tomorrow and I suspect we'll see significant buying and uplift now.
@riskisreward the trial is long completed and results and data now published ref @PALOH_study. NICE how issued MIB.
Why therefore are you trying to make out that the first commercial installations are a trial? I surmise you are spreading this patently false information purely as a deramp. As such, your posting is worthless, go do something useful elsewhere and try to be honest when you do it.
Key thing about NICE MIB is the COMMISSIONED BY NHS bit ("MIBs are commissioned by NHS England and published by NICE to inform NHS clinicians and managers about new technologies for their decision-making, commissioning and/or policy development.")
I would say that DB is probably MORE than just "pleased that the Genedrive® MT-RNR1 tests was selected for a MIB review"